Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-93.19%Return on Equity
VS
Market
Sector
Industry
History
$ 1.52Close
$ 0.29 - $ 2.03 52-Week Range
Ticker Information
Ticker
LXRXCompany Name
LEXICON PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLEXICON PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LXRX - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 129.44M | $ -120.62M | -93.19% |
| 3/31/2025 | $ 123.03M | $ -177.3M | -144.11% |
| 12/31/2024 | $ 145.95M | $ -200.4M | -137.31% |
| 9/30/2024 | $ 178.51M | $ -216.39M | -121.22% |
| 6/30/2024 | $ 239.98M | $ -202.11M | -84.22% |
| 3/31/2024 | $ 288.87M | $ -193.58M | -67.01% |
| 12/31/2023 | $ 93.11M | $ -177.12M | -190.23% |
| 9/30/2023 | $ 139.51M | $ -157.86M | -113.15% |
| 6/30/2023 | $ 186.36M | $ -130.72M | -70.14% |
| 3/31/2023 | $ 88.05M | $ -110.4M | -125.39% |
Key Performance Insights, Last 5 Years
- LEXICON PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at -118.92%.
- Over the past 5 years, LEXICON PHARMACEUTICALS INC's average ROE has been -89.92%.
- The median ROE for LEXICON PHARMACEUTICALS INC during this period was -90.11%
- LEXICON PHARMACEUTICALS INC reached its highest ROE over the past 5 years at 27.75%.
- The lowest ROE recorded by LEXICON PHARMACEUTICALS INC in the same timeframe -190.23%
LEXICON PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for LEXICON PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -104.22M ] / Equity [ $ 87.64M ]
(=) ROE [ -118.92% ] LXRX - Return on Equity, Last 5 years
-190.23%
Minimum
Dec 31, 2023
27.75%
Maximum
Jun 30, 2021
-89.92%
Average
-90.11%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.68% |